Office-based buprenorphine offers a second chance.
Sederer
Lloyd I
LI
Kolodny
Andrew
A
D000293:Adolescent; D002047:Buprenorphine / Q000627:therapeutic use*; D002648:Child; D006293:Health Promotion; D006556:Heroin Dependence / Q000188:drug therapy*; D006801:Humans; D007348:Insurance, Health; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009819:Office Visits; D013240:Stereotyping
D009292:Narcotic Antagonists; D002047:Buprenorphine